You're reading the free version. Trader adds the live tape and alerts.
Start tracking
SYRE Sale Disclosure
Burrows Scott L · SEC Form 4 · Filed Jun 26, 2026
Sale
Calculated transaction value
$435.6K
Burrows Scott L Chief Financial Officer
SYRE
Spyre Therapeutics
SYRE
Transaction date
Jun 25, 2026
Public filing date
Jun 26, 2026
Filing lag
Filed 1 day later
SYRE daily price context
Close on/before transaction
$88.67
Jun 25, 2026
First close after public filing
$90.16
Jun 29, 2026
30-day return after filing
+10.96%
Through Jul 27, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 5,000 shares @ $87.12
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001853327-26-000008
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$1.52M
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Spyre Therapeutics, Inc. SYRE | Exercise | Jun 25, 2026 | $217.5K |
| Spyre Therapeutics, Inc. SYRE Current | Sale | Jun 25, 2026 | $435.6K |
| Spyre Therapeutics, Inc. SYRE | Sale | Jun 25, 2026 | $871.4K |
| Spyre Therapeutics, Inc. SYRE | Exercise | Jun 25, 2026 | $0 |